NSE shareholding pattern
Piramal Pharma Limited shareholding pattern
As of the Sep 2026 shareholding pattern (quarter ended 2026-09-30), promoters held 34.8%, FIIs 13.65%, and DIIs 14.4% of Piramal Pharma Limited (PPLPHARMA). Against the Jun 2026 pattern, FII holding is up 1.14 percentage points (12.51% → 13.65%), DII down 0.17 points (14.57% → 14.4%), and promoter holding unchanged at 34.8%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns for the quarter ended 30 Sep 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Piramal Pharma Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Sep 2026 | 34.8 | 13.65 | 14.4 | 37.15 | 2026-09-30 |
| Jun 2026 | 34.8 | 12.51 | 14.57 | 38.12 | 2026-06-30 |
| Mar 2026 | 34.86 | 30.17 | 15.61 | 19.36 | 2026-03-31 |
| Dec 2025 | 34.86 | 29.66 | 15.68 | 19.8 | 2025-12-31 |
| Sep 2025 | 34.86 | 30.27 | 14.89 | 19.98 | 2025-09-30 |
| Jun 2025 | 34.86 | 30.86 | 14.25 | 20.03 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Piramal Pharma Limited
6 independent managers6 independent managers disclosed positions in Piramal Pharma Limited within the same window (Jul 11, 2026 – Oct 9, 2026), per filings across sources. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- Shareholding patterns for other companies in the same industry: Procter & Gamble Health Limited, Rubicon Research Limited, Sai Life Sciences Limited, Sanofi Consumer Healthcare India Limited, Sanofi India Limited, Shilpa Medicare Ltd, Solara Active Pharma Sciences Limited, Strides Pharma Science Ltd
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Piramal Pharma Limited?
As of the Sep 2026 shareholding pattern, promoters held 34.8% of Piramal Pharma Limited (PPLPHARMA). Figures are taken from the NSE shareholding pattern filing dated 2026-09-30 and may change each quarter. Not investment advice.
What is the FII holding in Piramal Pharma Limited?
Foreign institutional investors held 13.65% of Piramal Pharma Limited as of the Sep 2026 pattern, versus 12.51% in the Jun 2026 pattern. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How much did FII holding in Piramal Pharma Limited change in the Sep 2026 quarter?
FII holding in Piramal Pharma Limited was 12.51% in the Jun 2026 pattern and 13.65% in Sep 2026, a difference of 1.14 percentage points up. Promoter holding was unchanged at 34.8% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.